Topp, Max S.
Zimmerman, Zachary
Kantarjian, Hagop M.
Article History
First Online: 23 August 2016
Competing interests
: M.S.T. declares the receipt of personal fees and nonfinancial support from Amgen Inc. for work performed outside of the blinatumomab trials. Z.Z. declares that he is employed by and holds stock in Amgen Inc. H.M.K. declares no competing interests.